CClinicalTrials.gg
CompletedNCT05087979Updated Apr 8, 2024Results posted

Use of Stable Airway Management Device in Monitored Anesthesia Care

An interventional study of Stable airway management (SAM) device in Anesthesia, sponsored by Virginia Commonwealth University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-08.

Sponsored by Virginia Commonwealth University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to determine if the Stable Airway Management device (SAM) is safe in maintaining the airway in a stable, non-obstructing position during anesthetic cases requiring monitored anesthesia care (MAC).

Read the detailed description

Patients undergoing monitored anesthesia care as part of a procedure will be invited to participate in the study.

The stable airway management (SAM) device is an investigational device used to hold patient's head and airway in a stable position during a MAC procedure. An investigational device means it has not been approved by the U. S. Food and Drug Administration (FDA). In this study, the SAM will be compared to the standard of anesthesia care which consists of supporting patient's head, neck, and shoulders with pillows and towels when placing them in the correct position for the procedure.

02

Conditions studied

  • Anesthesia

Keywords

  • monitored anesthesia care
03

In context

Lead sponsor

Virginia Commonwealth University is the lead sponsor of 641 studies on the registry; 82 are open to participants now.

Of its 88 completed or terminated interventional studies of FDA-regulated products, 62 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patients undergoing MAC anesthesia in the supine position
  2. Patients able to give informed consent

Exclusion criteria

Exclusion Criteria:

  1. Age \< 18 years
  2. Less than 88% oxygen saturation on room air
  3. Non-elective procedures
  4. Case duration > 180 minutes
  5. Presence of a cervical spine injury, instability, or cervical spine collar
  6. Patients with airway, facial, or other anatomy deemed inappropriate for SAM use by anesthesiologist
  7. General anesthesia as primary anesthetic
  8. Prisoners
  9. Pregnant women
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Intervention

    An investigational device will be used to hold patient's head and airway in a stable position.

    Device: Stable airway management (SAM) device

  • No intervention
    Standard of care

    Pillows and towels will be used to hold patient's head and airway in a stable position.

Interventions

  • DeviceStable airway management (SAM) device

    SAM is positioning device that will maintain patient's head, neck, and therefore their airway in the correct position during their procedure.

06

What researchers measure

Primary outcomes

  1. Total Apneic Events /Total Number Requiring Airway Manipulation

    total number of apneic events greater than 20 seconds per 15-minute intervals, requiring airway manipulation - The median value of airway manipulations will be reported for each arm, along with the range of manipulations (low-high) for each study arm will be reported.

    Time frame: Up to 6 hours

  2. Number of Subjects Converted From MAC to General Anesthesia

    Number of participants converted from MAC to general anesthesia for airway-related complications

    Time frame: Up to 6 hours

07

Results

Posted Apr 8, 2024

Participant flow

Participant flow — Overall Study
MilestoneInterventionStandard of Care
Started2020
Completed1920
Not completed10
Withdrew: Converted to general anesthesia10

Outcome measures

PrimaryTotal Apneic Events /Total Number Requiring Airway Manipulation

total number of apneic events greater than 20 seconds per 15-minute intervals, requiring airway manipulation - The median value of airway manipulations will be reported for each arm, along with the range of manipulations (low-high) for each study arm will be reported.

Time frame:
Up to 6 hours
Reported as:
Median · Number of airway manipulations
Total Apneic Events /Total Number Requiring Airway Manipulation
Number of airway manipulationsInterventionStandard of Care
Total Apneic Events /Total Number Requiring Airway Manipulation2 (0 to 10)1 (0 to 11)
PrimaryNumber of Subjects Converted From MAC to General Anesthesia

Number of participants converted from MAC to general anesthesia for airway-related complications

Time frame:
Up to 6 hours
Reported as:
Number · participants
Number of Subjects Converted From MAC to General Anesthesia
participantsInterventionStandard of Care
Number of Subjects Converted From MAC to General Anesthesia10

Adverse events

Collected over Up to 3-4 days post procedure. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/20 (0%)0/20 (0%)0/20 (0%)
Standard of Care0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)InterventionStandard of CareTotal
Median61 (26 to 78)61 (38 to 84)61 (26 to 84)
Sex: Female, Male
Sex: Female, Male(Participants)InterventionStandard of CareTotal
Female131124
Male7916
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)InterventionStandard of CareTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)InterventionStandard of CareTotal
United States202040
08

Study locations

1 site
  • Virginia Commonwealth University
    Richmond, Virginia 23298, United States
09

References and documents

Study documents

  • Study protocol · Nov 4, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05087979
Lead sponsor
Virginia Commonwealth University
Responsible party
Sponsor
First posted
Oct 21, 2021
Start date
Jul 28, 2022
Primary completion
Sep 29, 2022
Completion
Sep 29, 2022
Results posted
Apr 8, 2024
Last update
Apr 8, 2024

Study contacts

Visnal Yajnik, MD
principal investigator · Virginia Commonwealth University

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion